DataVXJournal of Nanoparticle ResearchPaper
journal article·2025-04

Electrochemical synthesis of nano-hydroxyapatite homogeneously doped with europium and modified with folic acid

Agustín F. Solano-Arguedas, Natalia Ortiz, Mavis L. Montero

Journal of Nanoparticle Research· Volume 27· Issue 4
Publisher page
Bibliographic record

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Radioactive element chemistry and processing · Luminescence Properties of Advanced Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (85)

Show source-provided references
1. Jäger C, Welzel T, Meyer-Zaika W, Epple M (2006) A solid-state NMR investigation of the structure of nanocrystalline hydroxyapatite. Magn Reson Chem 44:573–580. https://doi.org/10.1002/mrc.177410.1002/mrc.1774 ↗
2. Sadat-Shojai M, Khorasani M-T, Dinpanah-Khoshdargi E, Jamshidi A (2013) Synthesis methods for nanosized hydroxyapatite with diverse structures. Acta Biomater 9:7591–7621. https://doi.org/10.1016/j.actbio.2013.04.01210.1016/j.actbio.2013.04.012 ↗
3. Dorozhkin SV (2010) Nanosized and nanocrystalline calcium orthophosphates. Acta Biomater 6:715–734. https://doi.org/10.1016/j.actbio.2009.10.03110.1016/j.actbio.2009.10.031 ↗
4. Lin K, Wu C, Chang J (2014) Advances in synthesis of calcium phosphate crystals with controlled size and shape. Acta Biomater 10:4071–4102. https://doi.org/10.1016/j.actbio.2014.06.01710.1016/j.actbio.2014.06.017 ↗
5. Kojima Y, Kitazawa K, Nishimiya N (2012) Synthesis of nano-sized hydroxyapatite by ultrasound irradiation. J Phys Conf Ser 339:1–4. https://doi.org/10.1088/1742-6596/339/1/01200110.1088/1742-6596/339/1/012001 ↗
6. Hassan MN, Mahmoud MM, El-Fattah AA, Kandil S (2016) Microwave-assisted preparation of nano-hydroxyapatite for bone substitutes. Ceram Int 42:3725–3744. https://doi.org/10.1016/j.ceramint.2015.11.04410.1016/j.ceramint.2015.11.044 ↗
7. Šupová M (2015) Substituted hydroxyapatites for biomedical applications: a review. Ceram Int 41:9203–9231. https://doi.org/10.1016/j.ceramint.2015.03.31610.1016/j.ceramint.2015.03.316 ↗
8. Lin K, Liu P, Wei L et al (2013) Strontium substituted hydroxyapatite porous microspheres: surfactant-free hydrothermal synthesis, enhanced biological response and sustained drug release. Chem Eng J 222:49–59. https://doi.org/10.1016/j.cej.2013.02.03710.1016/j.cej.2013.02.037 ↗
9. Geng Z, Cui Z, Li Z et al (2016) Strontium incorporation to optimize the antibacterial and biological characteristics of silver-substituted hydroxyapatite coating. Mater Sci Eng C 58:467–477. https://doi.org/10.1016/j.msec.2015.08.06110.1016/j.msec.2015.08.061 ↗
10. Ciobanu G, Maria Bargan A, Luca C (2015) New cerium(IV)-substituted hydroxyapatite nanoparticles: preparation and characterization. Ceram Int 41:12192–12201. https://doi.org/10.1016/j.ceramint.2015.06.04010.1016/j.ceramint.2015.06.040 ↗
11. Shepherd D, Best SM (2013) Production of zinc substituted hydroxyapatite using various precipitation routes. Biomed Mater 8:1–11. https://doi.org/10.1088/1748-6041/8/2/02500310.1088/1748-6041/8/2/025003 ↗
12. Da Silva E, Heyd DV, Rizvi B, Pejović-Milić A (2016) The preparation of strontium-substituted hydroxyapatite bone phantoms with high strontium concentrations. Biomed Phys Eng Express 2:1–8. https://doi.org/10.1088/2057-1976/2/1/01500610.1088/2057-1976/2/1/015006 ↗
13. Bose S, Tarafder S (2012) Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review. Acta Biomater 8:1401–1421. https://doi.org/10.1016/j.actbio.2011.11.01710.1016/j.actbio.2011.11.017 ↗
14. Bareiro O, Santos LA (2014) Tetraethylorthosilicate (TEOS) applied in the surface modification of hydroxyapatite to develop polydimethylsiloxane/hydroxyapatite composites. Colloids Surf B Biointerfaces 115:400–405. https://doi.org/10.1016/j.colsurfb.2013.12.02710.1016/j.colsurfb.2013.12.027 ↗
15. Fang Z, Feng Q (2014) Improved mechanical properties of hydroxyapatite whisker-reinforced poly(l-lactic acid) scaffold by surface modification of hydroxyapatite. Mater Sci Eng C 35:190–194. https://doi.org/10.1016/j.msec.2013.11.00810.1016/j.msec.2013.11.008 ↗
16. Rojas L, Olmedo H, García-Piñeres AJ et al (2015) Simple route for nano-hydroxyapatite properties expansion. Biomed Mater 10:055015. https://doi.org/10.1088/1748-6041/10/5/05501510.1088/1748-6041/10/5/055015 ↗
17. Syamchand SS, Sony G (2015) Europium enabled luminescent nanoparticles for biomedical applications. J Lumin 165:190–215. https://doi.org/10.1016/j.jlumin.2015.04.04210.1016/j.jlumin.2015.04.042 ↗
18. Daneshvar H, Shafaei M, Manouchehri F et al (2019) The role of La, Eu, Gd, and Dy lanthanides on thermoluminescence characteristics of nano-hydroxyapatite induced by gamma radiation. SN Appl Sci 1:1146. https://doi.org/10.1007/s42452-019-1162-410.1007/s42452-019-1162-4 ↗
19. Popa CL, Ciobanu CS, Iconaru SL et al (2014) Systematic investigation and in vitro biocompatibility studies on mesoporous europium doped hydroxyapatite. Cent Eur J Chem 12:1032–1046. https://doi.org/10.2478/s11532-014-0554-y10.2478/s11532-014-0554-y ↗
20. Kim EJ, Choi S-W, Hong S-H (2007) Synthesis and photoluminescence properties of Eu3+-doped calcium phosphates. J Am Ceram Soc 90:2795–2798. https://doi.org/10.1111/j.1551-2916.2007.01791.x10.1111/j.1551-2916.2007.01791.x ↗
21. Silva FRO, de Lima NB, Bressiani AHA et al (2015) Synthesis, characterization and luminescence properties of Eu3+-doped hydroxyapatite nanocrystal and the thermal treatment effects. Opt Mater (Amst) 47:135–142. https://doi.org/10.1016/j.optmat.2015.07.00610.1016/j.optmat.2015.07.006 ↗
22. Han Y, Wang X, Dai H, Li S (2013) Synthesis and luminescence of Eu3+ doped hydroxyapatite nanocrystallines: Effects of calcinations and Eu3+ content. J Lumin 135:281–287. https://doi.org/10.1016/j.jlumin.2012.09.02910.1016/j.jlumin.2012.09.029 ↗
23. Xing M, Xiaoming W, Yusheng Q (2015) Preparation and characterization of europium-doped nanohydroxyapatite (Eu-nHA) fluorescent agent. Rare Met Mater Eng 44:32–35. https://doi.org/10.1016/S1875-5372(15)30007-210.1016/S1875-5372(15)30007-2 ↗
24. Zhao Y, Zhu J, Zhu S et al (2011) Synthesis and characterization of arginine-modified and europium-doped hydroxyapatite nanoparticle and its cell viability. Trans Nonferrous Met Soc China 21:1773–1778. https://doi.org/10.1016/S1003-6326(11)60929-110.1016/S1003-6326(11)60929-1 ↗
25. Xuan T-C, Trung NN, Pham V-H (2015) Comparative characterization of microstructure and luminescence of europium doped hydroxyapatite nanoparticles via coprecipitation and hydrothermal method. Optik (Stuttg) 126:5019–5021. https://doi.org/10.1016/j.ijleo.2015.09.13610.1016/j.ijleo.2015.09.136 ↗
26. Sun Y, Yang H, Tao D (2011) Microemulsion process synthesis of lanthanide-doped hydroxyapatite nanoparticles under hydrothermal treatment. Ceram Int 37:2917–2920. https://doi.org/10.1016/j.ceramint.2011.03.03010.1016/j.ceramint.2011.03.030 ↗
27. Escudero A, Calvo ME, Rivera-Fernández S et al (2013) Microwave-assisted synthesis of biocompatible europium-doped calcium hydroxyapatite and fluoroapatite luminescent nanospindles functionalized with poly(acrylic acid). Langmuir 29:1985–1994. https://doi.org/10.1021/la304534f10.1021/la304534f ↗
28. Wagner DE, Eisenmann KM, Nestor-Kalinoski AL, Bhaduri SB (2013) A microwave-assisted solution combustion synthesis to produce europium-doped calcium phosphate nanowhiskers for bioimaging applications. Acta Biomater 9:8422–8432. https://doi.org/10.1016/j.actbio.2013.05.03310.1016/j.actbio.2013.05.033 ↗
29. Graeve OA, Kanakala R, Madadi A et al (2010) Luminescence variations in hydroxyapatites doped with Eu2+ and Eu3+ ions. Biomaterials 31:4259–4267. https://doi.org/10.1016/j.biomaterials.2010.02.00910.1016/j.biomaterials.2010.02.009 ↗
30. Li H, Mei L, Liu H et al (2017) Growth mechanism of surfactant-free size-controlled luminescent hydroxyapatite nanocrystallites. Cryst Growth Des 17:2809–2815. https://doi.org/10.1021/acs.cgd.7b0025810.1021/acs.cgd.7b00258 ↗
31. Kataoka T, Shiba K, Tagaya M (2016) Preparation of europium(III)-doped hydroxyapatite nanocrystals in the presence of cationic surfactant. Colloid Interface Sci Commun 13:1–5. https://doi.org/10.1016/j.colcom.2016.04.00310.1016/j.colcom.2016.04.003 ↗
32. Chen F, Zhu Y-J, Zhang K-H et al (2011) Europium-doped amorphous calcium phosphate porous nanospheres: preparation and application as luminescent drug carriers. Nanoscale Res Lett 6:1–9. https://doi.org/10.1186/1556-276X-6-6710.1186/1556-276X-6-67 ↗
33. Silva FRO, Lima NB, Guilhen SN et al (2016) Evaluation of europium-doped HA/β-TCP ratio fluorescence in biphasic calcium phosphate nanocomposites controlled by the pH value during the synthesis. J Lumin 180:177–182. https://doi.org/10.1016/j.jlumin.2016.08.03010.1016/j.jlumin.2016.08.030 ↗
34. Nabiyouni M, Zhou H, Bhaduri SB (2013) Microwave assisted solution combustion synthesis (MASCS) of europium (Eu) doped chlorapatite nanowhiskers. Mater Lett 108:54–57. https://doi.org/10.1016/j.matlet.2013.06.08910.1016/j.matlet.2013.06.089 ↗
35. Sun Y, Yang H, Tao D (2012) Preparation and characterization of Eu3+-doped fluorapatite nanoparticles by a hydrothermal method. Ceram Int 38:6937–6941. https://doi.org/10.1016/j.ceramint.2012.05.03610.1016/j.ceramint.2012.05.036 ↗
36. Thang CX, Pham V-H (2015) Luminescence variations in europium-doped silicon-substituted hydroxyapatite nanobiophosphor via three different methods. Mater Sci Eng B 197:18–24. https://doi.org/10.1016/j.mseb.2015.02.01410.1016/j.mseb.2015.02.014 ↗
37. Chen M-H, Yoshioka T, Ikoma T et al (2016) Photoluminescence and doping mechanism of theranostic Eu 3+ /Fe 3+ dual-doped hydroxyapatite nanoparticles. Sci Technol Adv Mater 15:1–9. https://doi.org/10.1088/1468-6996/15/5/05500510.1088/1468-6996/15/5/055005 ↗
38. Garcia-Bennett A, Nees M, Fadeel B (2011) In search of the holy grail: folate-targeted nanoparticles for cancer therapy. Biochem Pharmacol 81:976–984. https://doi.org/10.1016/j.bcp.2011.01.02310.1016/j.bcp.2011.01.023 ↗
39. Holm J, Bruun SW, Hansen SI (2015) The complex interplay between ligand binding and conformational structure of the folate binding protein (folate receptor): Biological perspectives. Biochim Biophys Acta - Proteins Proteomics 1854:1249–1259. https://doi.org/10.1016/j.bbapap.2015.06.00910.1016/j.bbapap.2015.06.009 ↗
40. Assaraf YG, Leamon CP, Reddy JA (2014) The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resist Updat 17:89–95. https://doi.org/10.1016/j.drup.2014.10.00210.1016/j.drup.2014.10.002 ↗
41. Leung F, Dimitromanolakis A, Kobayashi H et al (2013) Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients. Clin Biochem 46:1462–1468. https://doi.org/10.1016/j.clinbiochem.2013.03.01010.1016/j.clinbiochem.2013.03.010 ↗
42. Scomparin A, Salmaso S, Eldar-Boock A et al (2015) A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index. J Control Release 208:106–120. https://doi.org/10.1016/j.jconrel.2015.04.00910.1016/j.jconrel.2015.04.009 ↗
43. Mironava T, Simon M, Rafailovich MH, Rigas B (2013) Platinum folate nanoparticles toxicity: cancer vs. normal cells. Toxicol Vitr 27:882–889. https://doi.org/10.1016/j.tiv.2013.01.00510.1016/j.tiv.2013.01.005 ↗
44. Venkatasubbu GD, Ramasamy S, Ramakrishnan V, Kumar J (2013) Folate targeted PEGylated titanium dioxide nanoparticles as a nanocarrier for targeted paclitaxel drug delivery. Adv Powder Technol 24:947–954. https://doi.org/10.1016/j.apt.2013.01.00810.1016/j.apt.2013.01.008 ↗
45. Yin J-J, Sharma S, Shumyak SP et al (2013) Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment. PLoS ONE 8:1–20. https://doi.org/10.1371/journal.pone.006228910.1371/journal.pone.0062289 ↗
46. Nukolova NV, Oberoi HS, Cohen SM et al (2011) Folate-decorated nanogels for targeted therapy of ovarian cancer. Biomaterials 32:5417–5426. https://doi.org/10.1016/j.biomaterials.2011.04.00610.1016/j.biomaterials.2011.04.006 ↗
47. Lu Y, Low PS (2012) Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 64:342–352. https://doi.org/10.1016/j.addr.2012.09.02010.1016/j.addr.2012.09.020 ↗
48. Feng D, Song Y, Shi W et al (2013) Distinguishing folate-receptor-positive cells from folate-receptor-negative cells using a fluorescence off−on nanoprobe. Anal Chem 85:6530–6535. https://doi.org/10.1021/ac401377n10.1021/ac401377n ↗
49. Venkatasubbu GD, Ramasamy S, Avadhani GS et al (2013) Surface modification and paclitaxel drug delivery of folic acid modified polyethylene glycol functionalized hydroxyapatite nanoparticles. Powder Technol 235:437–442. https://doi.org/10.1016/j.powtec.2012.11.00310.1016/j.powtec.2012.11.003 ↗
50. Ansari L, Derakhshi M, Bagheri E et al (2020) Folate conjugation improved uptake and targeting of porous hydroxyapatite nanoparticles containing epirubicin to cancer cells. Pharm Dev Technol 25:601–609. https://doi.org/10.1080/10837450.2020.172504510.1080/10837450.2020.1725045 ↗
51. Ashokan A, Menon D, Nair S, Koyakutty M (2010) A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent. Biomaterials 31:2606–2616. https://doi.org/10.1016/j.biomaterials.2009.11.11310.1016/j.biomaterials.2009.11.113 ↗
52. Cipreste MF, Gonzalez I, da Mata M, Martins T et al (2016) Attaching folic acid on hydroxyapatite nanorod surfaces: an investigation of the HA–FA interaction. RSC Adv 6:76390–76400. https://doi.org/10.1039/C6RA14068H10.1039/C6RA14068H ↗
53. Al-Kattan A, Girod-Fullana S, Charvillat C et al (2012) Biomimetic nanocrystalline apatites: emerging perspectives in cancer diagnosis and treatment. Int J Pharm 423:26–36. https://doi.org/10.1016/j.ijpharm.2011.07.00510.1016/j.ijpharm.2011.07.005 ↗
54. Sánchez Lafarga AK, Pacheco Moisés FP, Gurinov A et al (2015) Dual responsive dysprosium-doped hydroxyapatite particles and toxicity reduction after functionalization with folic and glucuronic acids. Mater Sci Eng C 48:541–547. https://doi.org/10.1016/j.msec.2014.12.03310.1016/j.msec.2014.12.033 ↗
55. Santos C, Gomes P, Duarte JA et al (2017) Development of hydroxyapatite nanoparticles loaded with folic acid to induce osteoblastic differentiation. Int J Pharm 516:185–195. https://doi.org/10.1016/j.ijpharm.2016.11.03510.1016/j.ijpharm.2016.11.035 ↗
56. Quindoza GM, Horimoto R, Nakagawa Y et al (2024) Folic acid-mediated enhancement of the diagnostic potential of luminescent europium-doped hydroxyapatite nanocrystals for cancer biomaging. Colloids Surf B Biointerfaces 239:113975. https://doi.org/10.1016/j.colsurfb.2024.11397510.1016/j.colsurfb.2024.113975 ↗
57. Yan T, Weng F, Ming Y et al (2024) Luminescence probes in bio-applications: from principle to practice. Biosensors 14. https://doi.org/10.3390/bios1407033310.3390/bios14070333 ↗
58. Tan S, Li S, Tang C et al (2022) A regenerable and reducing false-positive fluorescent switch for detection of β-amyloid 1–42 oligomers. Talanta 246:123461. https://doi.org/10.1016/j.talanta.2022.12346110.1016/j.talanta.2022.123461 ↗
59. Luo X, Zhang C, Yu Z et al (2023) Recent advances in responsive lanthanide-doped luminescence nanoprobes in the near-infrared-II window. TrAC Trends Anal Chem 169:117368. https://doi.org/10.1016/j.trac.2023.11736810.1016/j.trac.2023.117368 ↗
60. Montalbert-Smith Echeverría R, Montero ML (2013) Electrolytic one-pot synthesis of Group II nanohydroxyapatites. J Mater Sci 48:5253–5260. https://doi.org/10.1007/s10853-013-7316-710.1007/s10853-013-7316-7 ↗
61. Montero ML, Sáenz A, Rodríguez JG et al (2006) Electrochemical synthesis of nanosized hydroxyapatite. J Mater Sci 41:2141–2144. https://doi.org/10.1007/s10853-006-5231-x10.1007/s10853-006-5231-x ↗
62. Rasband WS (1997-2018) ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA. https://imagej.net/ij/
63. Chen H, Ahn R, Van den Bossche J et al (2009) Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide. Mol Cancer Ther 8:1955–1963. https://doi.org/10.1158/1535-7163.MCT-09-0045.Folate-mediated10.1158/1535-7163.MCT-09-0045.Folate-mediated ↗
64. Riss TL, Moravec RA, Niles AL, et al (2004) Cell Viability Assays. 2013 May 1 [Updated 2016 Jul 1]. In: Markossian S, Grossman A, Arkin M, et al., (eds) Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences. Available from: https://www.ncbi.nlm.nih.gov/books/NBK144065/
65. JMP® Pro, Version 15.0.0 (2019) SAS Institute Inc., Cary, NC, 1989–2019
66. Kabekkodu S, Dosen A, Blanton T (2024) PDF-5+: a comprehensive Powder Diffraction File™ for materials characterization. Powder Diffract 39(2):47–59. https://doi.org/10.1017/S088571562400015010.1017/S0885715624000150 ↗
67. Bang LT, Ramesh S, Purbolaksono J et al (2015) Effects of silicate and carbonate substitution on the properties of hydroxyapatite prepared by aqueous co-precipitation method. Mater Des 87:788–796. https://doi.org/10.1016/j.matdes.2015.08.06910.1016/j.matdes.2015.08.069 ↗
68. Antonakos A, Liarokapis E, Leventouri T (2007) Micro-Raman and FTIR studies of synthetic and natural apatites. Biomaterials 28:3043–3054. https://doi.org/10.1016/j.biomaterials.2007.02.02810.1016/j.biomaterials.2007.02.028 ↗
69. Boanini E, Gazzano M, Bigi A (2010) Ionic substitutions in calcium phosphates synthesized at low temperature. Acta Biomater 6:1882–1894. https://doi.org/10.1016/j.actbio.2009.12.04110.1016/j.actbio.2009.12.041 ↗
70. Liu Q, Matinlinna JP, Chen Z et al (2015) Effect of thermal treatment on carbonated hydroxyapatite: morphology, composition, crystal characteristics and solubility. Ceram Int 41:6149–6157. https://doi.org/10.1016/j.ceramint.2014.11.06210.1016/j.ceramint.2014.11.062 ↗
71. Lafon JP, Champion E, Bernache-Assollant D et al (2003) Termal decomposition of carbonated calcium phosphate apatites. J Therm Anal Calorim 72:1127–1134. https://doi.org/10.1023/A:102503621404410.1023/A:1025036214044 ↗
72. Matias R, Ribeiro PRS, Sarraguca MC, Lopes JA (2014) A UV spectrophotometric method for the determination of folic acid in pharmaceutical tablets and dissolution tests. Anal Methods 6:3065–3071. https://doi.org/10.1039/C3AY41874J10.1039/C3AY41874J ↗
73. Vora A, Riga A, Dollimore D, Alexander KS (2002) Thermal stability of folic acid. Thermochim Acta 392–393:209–220. https://doi.org/10.1016/S0040-6031(02)00103-X10.1016/S0040-6031(02)00103-X ↗
74. Hesse M, Meier H, Zeeh B (1997) Spectroscopic methods in organic chemistry. Thieme, New York
75. Xie Y, Perera TSH, Li F et al (2015) Quantitative detection method of hydroxyapatite nanoparticles based on Eu 3+ fluorescent labeling in vitro and in vivo. ACS Appl Mater Interfaces 7:23819–23823. https://doi.org/10.1021/acsami.5b0876710.1021/acsami.5b08767 ↗
76. Quindoza GM, Mizuno HL, Matsuyama Y et al (2024) Substitution of europium (III) in hydroxyapatite lattice for luminescence applications: integrating experimental and theoretical insights. Ceram Int 50:39698–39709. https://doi.org/10.1016/j.ceramint.2024.07.34910.1016/j.ceramint.2024.07.349 ↗
77. Gaft M, Reisfeld R, Panczer G et al (1997) Eu3+ luminescence in high-symmetry sites of natural apatite. J Lumin 72–74:572–574. https://doi.org/10.1016/S0022-2313(96)00229-310.1016/S0022-2313(96)00229-3 ↗
78. Binnemans K (2015) Interpretation of europium(III) spectra. Coord Chem Rev 295:1–45. https://doi.org/10.1016/j.ccr.2015.02.01510.1016/j.ccr.2015.02.015 ↗
79. Chen C, Ke J, Zhou XE et al (2013) Structural basis for molecular recognition of folic acid by folate receptors. Nature 500:486–489. https://doi.org/10.1038/nature1232710.1038/nature12327 ↗
80. Pi J, Jin H, Liu R et al (2013) Pathway of cytotoxicity induced by folic acid modified selenium nanoparticles in MCF-7 cells. Appl Microbiol Biotechnol 97:1051–1062. https://doi.org/10.1007/s00253-012-4359-710.1007/s00253-012-4359-7 ↗
81. Yan H, You Y, Li X et al (2020) Preparation of RGD peptide/folate acid double-targeted mesoporous silica nanoparticles and its application in human breast cancer MCF-7 cells. Front Pharmacol 11. https://doi.org/10.3389/fphar.2020.0089810.3389/fphar.2020.00898 ↗
82. Soleymani J, Hasanzadeh M, Somi MH et al (2018) Probing the specific binding of folic acid to folate receptor using amino-functionalized mesoporous silica nanoparticles for differentiation of MCF 7 tumoral cells from MCF 10A. Biosens Bioelectron 115:61–69. https://doi.org/10.1016/j.bios.2018.05.02510.1016/j.bios.2018.05.025 ↗
83. Geethakumari D, Bhaskaran Sathyabhama A, Raji Sathyan K et al (2022) Folate functionalized chitosan nanoparticles as targeted delivery systems for improved anticancer efficiency of cytarabine in MCF-7 human breast cancer cell lines. Int J Biol Macromol 199:150–161. https://doi.org/10.1016/j.ijbiomac.2021.12.07010.1016/j.ijbiomac.2021.12.070 ↗
84. Motskin M, Wright DM, Muller K et al (2009) Hydroxyapatite nano and microparticles: correlation of particle properties with cytotoxicity and biostability. Biomaterials 30:3307–3317. https://doi.org/10.1016/j.biomaterials.2009.02.04410.1016/j.biomaterials.2009.02.044 ↗
85. Gómez Morales J, Fernández Penas R, Verdugo-Escamilla C et al (2019) Bioinspired mineralization of type I collagen fibrils with apatite in presence of citrate and europium ions. Crystals 9. https://doi.org/10.3390/cryst901001310.3390/cryst9010013 ↗